Nerve modulation to treat diabetes

1. A method of treating a subject having diabetes or symptoms associated with diabetes, comprising:

inserting a radiofrequency (RF) catheter into vasculature of a subject;

positioning a distal end of the RF catheter within a portion of the common hepatic artery of the vasculature; and

using the RF catheter to intravascularly deliver RF energy to a wall of the common hepatic artery sufficient to denervate one or more nerves surrounding the liver to treat one or more symptoms associated with diabetes,

wherein the RF catheter comprises at least one electrode, and

wherein the at least one electrode is configured to contact the wall of the common hepatic artery while the RF energy is being delivered.

2. The method of claim 1 , wherein treatment of the one or more symptoms comprises a reduction of a norepinephrine level in the subject.

3. The method of claim 1 , wherein treatment of the one or more symptoms comprises improving lipid profile in the subject.

4. The method of claim 1 , wherein treatment of the one or more symptoms comprises at least one of: reducing a triglyceride level in the subject, improvement of beta cell function in the subject and increasing insulin production.

5. The method of claim 1 , wherein the one or more nerves are sympathetic nerves of the hepatic plexus.

6. The method of claim 1 , wherein a contact pressure between 0.1 g/mm 2 and 100 g/mm 2 is exerted on the wall by the RF catheter.

7. The method of claim 1 , wherein the RF energy delivered by the at least one electrode to the wall is in the range of between 100 J and 1 kJ.

8. The method of claim 5 ,

wherein the RF energy is delivered at a frequency in the range of 50 kHz to 5 MHz; and

wherein the RF energy is delivered to heat the one or more sympathetic nerves sufficient to cause ablation of the one or more sympathetic nerves.

9. The method of claim 1 , further comprising at least partially occluding flow within the common hepatic artery.

10. A method of treating a subject having diabetes or symptoms associated with diabetes, comprising:

intravascularly delivering a distal portion of a radiofrequency (RF) energy delivery catheter to a vicinity of a liver of a subject;

disrupting neural communication along a sympathetic nerve fiber by causing RF energy to be emitted from one or more electrodes positioned on the distal portion of the RF energy delivery catheter to treat one or more symptoms associated with diabetes; and

removing the RF energy delivery catheter from the subject.

11. The method of claim 10 , wherein the RF energy delivery catheter is delivered intravascularly through a femoral or radial artery to a location within the common hepatic artery.

12. The method of claim 10 , wherein intravascularly delivering a distal portion of the RF energy delivery catheter to the vicinity of the liver of the subject comprises positioning the one or more electrodes of the RF energy delivery catheter within a portion of the common hepatic artery.

13. The method of claim 10 , wherein disrupting neural communication comprises permanent termination of nerve conduction along the sympathetic nerve fiber.

14. The method of claim 10 , wherein disrupting neural communication comprises temporarily slowing or terminating nerve conduction along the sympathetic nerve fiber.

15. The method of claim 10 , wherein disrupting neural communication along a sympathetic nerve fiber comprises disrupting neural communication along a plurality of sympathetic nerve fibers of the hepatic plexus simultaneously.

16. The method of claim 10 , further comprising positioning the RF energy delivery catheter in the vicinity of nerve fibers that innervate the pancreas and disrupting neural communication along the nerve fibers by causing RF energy to be emitted from one or more electrodes of the RF energy delivery catheter.

17. The method of claim 10 ,

wherein the RF energy is emitted at a frequency in the range of 50 kHz to 5 MHz, and

wherein the RF energy emitted is sufficient to cause ablation of the one or more sympathetic nerves.

18. A method of treating a subject having diabetes or symptoms associated with diabetes, comprising:

providing an energy delivery catheter configured for:

accessing a portion of vasculature in the vicinity of a liver of a subject; and

delivering energy through a wall of the vasculature to one or more nerves surrounding the vasculature,

wherein the delivered energy is sufficient to terminate nerve conduction along the one or more nerves to treat one or more symptoms associated with diabetes.

19. The method of claim 18 , wherein the termination of nerve conduction comprises permanent ablation of the one or more nerves.

20. The method of claim 18 , wherein the termination of nerve conduction comprises temporary termination of nerve conduction of the one or more nerves.